-
Jan 14, 2025 | 
medicalxpress.com | Julia Evangelou Strait
A new type of cell-based immunotherapy shows promise for B-cell lymphomas, and due to innovations in manufacturing, could make future cellular immunotherapies less expensive and more accessible to patients. A phase 1 clinical trial has found one such immunotherapy to be safe for patients with several types of B-cell lymphoma, a type of blood cancer.
-
Dec 5, 2024 | 
medicalxpress.com | Julia Evangelou Strait
A new study from Washington University School of Medicine in St. Louis describes an innovative method of analyzing mammograms that significantly improves the accuracy of predicting the risk of breast cancer development over the following five years.
-
Dec 5, 2024 | 
medicine.washu.edu | Julia Evangelou Strait |Julia Strait |Brittney Wheeler
Adding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening side effect, according to an early-stage clinical trial conducted at Washington University School of Medicine in St. Louis. The trial showed that patients being treated for various blood cancers tolerated the investigational drug — called itacitinib —and experienced lower-than-expected rates of graft-versus-host disease (GvHD), in which the donor’s stem cells attack the patient’s healthy tissues.
-
Dec 5, 2024 | 
medicalxpress.com | Julia Evangelou Strait
Adding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening side effect, according to an early-stage clinical trial conducted at Washington University School of Medicine in St. Louis.
-
Nov 13, 2024 | 
medicine.washu.edu | Julia Evangelou Strait
Zhang X, Goedegebuure P, Chen MY, Mishra R, Zhang F, Yu YY, Singhal K, Li L, Gao F, Myers NB, Vickery T, Hundal J, McLellan MD, Sturmoski MA, Kim SW, Chen I, Davidson JT, Sankpal NV, Myles S, Suresh R, Ma CX, Foluso A, Wang-Gillam A, Davies S, Hagemann IS, Mardis ER, Griffith O, Griffith M, Miller CA, Hansen TH, Fleming TP, Schreiber RD, Gillanders WE. Neoantigen DNA vaccines are safe, feasible, and induce neoantigen-specific immune responses in triple-negative breast cancer patients.
-
Aug 15, 2024 | 
pressreleasepoint.com | Julia Evangelou Strait
Submitted by Washington Univ... on Thu, 08/15/2024 - 06:22 MOKALLED LAB The top image shows fluorescently labeled cells in the spinal cord of a zebrafish recovering one week after an injury, and the bottom image shows recovery four weeks after an injury. Researchers at Washington University School of Medicine in St. Louis describe the dramatic changes within nerve cells that make regeneration possible.
-
May 11, 2024 | 
pressreleasepoint.com | Julia Evangelou Strait
Primary tabsView(active tab)Track Submitted by Washington Univ... on Fri, 05/10/2024 - 22:20 Getty Images The Leukemia & Lymphoma Society (LLS) has given a $5 million grant to researchers at Washington University School of Medicine in St. Louis to support research aimed at developing new immunotherapies for different types of blood-based cancers. Shown is an artist's rendering of a natural killer cell — a type of immune cell — attacking a cancer cell.
-
Mar 28, 2024 | 
medicalxpress.com | Julia Evangelou Strait
A clinical trial led by researchers at Washington University School of Medicine in St. Louis has shown that a T cell immunotherapy—in which the patients' own T cells are genetically modified to attack and kill cancer cells—is effective in treating some patients with rare cancers of the body's soft tissues. The study, which focused on the rare cancers synovial sarcoma and myxoid round cell liposarcoma (MRCLS), is published in The Lancet.
-
Jan 29, 2024 | 
medicalxpress.com | Julia Evangelou Strait
Diagnoses of breast cancer have increased steadily in women under age 50 over the past two decades, with steeper increases in more recent years, according to a study led by researchers at Washington University School of Medicine in St. Louis. The surge is driven largely by increases in the number of women diagnosed with estrogen-receptor positive tumors, cancerous growths fueled by estrogen.
-
Jan 9, 2024 | 
n9.cl | Julia Evangelou Strait |Enrique Jimenez |Enrique Jiménez
In recent years, research has begun to reveal that the lines of communication between the body’s organs are key regulators of aging. When these lines are open, the body’s organs and systems work well together. But with age, communication lines deteriorate, and organs don’t get the molecular and electrical messages they need to function properly.
